Skip to the care guide
Tesamorelin The care checkbook Chapter index
Open the guide
Start with the reason
Check the person
Check the medicine
Check the visit
Take your questions
Check the full bill
Check risks and follow-up
Check the evidence
A guide to finding and checking care
Tesamorelin doctors: check before you choose.
This is a guide to finding and checking tesamorelin care. It has no doctor listings and does not offer visits or medicine.
Start the first check →
First, what is being offered?
A hormone is a chemical that carries messages within the body; tesamorelin copies one made in the brain.
It makes the body release more of its own growth hormone, another chemical messenger.
For adults with HIV-related lipodystrophy, tesamorelin (Egrifta SV, Egrifta WR) has US approval to reduce excess belly fat, as of September 2026.
For this guide, the letters FDA mean the US drug agency: Food and Drug Administration.
HIV is a virus; treatment for it can change how body fat is spread, a change called lipodystrophy.
The September 2026 label says tesamorelin is not meant for weight-loss care.
Check an option in this order
A search result can sound convincing. Put it through the same checks each time. Keep the answers in a note, so a warm sales pitch does not crowd them out.
The reason
What health problem is the treatment meant to address?
The person
Who would assess you, and can you check their licence?
The product
What exact medicine would be prescribed?
The plan
How would progress, new symptoms and the bill be handled?
Begin with the reason for care →
One offer deserves a hard pause
By September 2026, US law treated tesamorelin as a biologic, a type of medicine whose approval rules do not allow pharmacy-made copies.
Those US rules do not let a pharmacy make its own tesamorelin.
Compounding means making a medicine to order.
An offer of “compounded tesamorelin” is not just a price question.
Read the medicine checks →
Go straight to the check you need
The person: check a licence →
Find the public record behind the name.
The visit: know what care involves →
Find out what the assessment involves and how care continues afterwards.
The bill: ask for a full total →
Separate the visit, tests and medicine.
The risks: know what needs attention →
Read the label checks and urgent signs.
The evidence: test the claims →
See what the trials found and what they cannot promise.
Your questions: take a written list →
Leave the visit with answers you can compare.
Source notes for this chapter
DailyMed: tesamorelin (Egrifta WR) label
For the approved use and the limits of treatment.
FDA: compounding questions and answers
For the rule on pharmacies making copies of this type of medicine.
Take a question list → Start with the reason →
This checkbook helps you question tesamorelin care; it is a guide, never a clinic or a place that sells treatment.
Guide opening Back to the chapter top ↑ Read the text copy